XOMAP Q1 2023 Earnings — XOMA Corporation Revenue & Financial Results | Market Cap Arena

XOMAPXOMA Corporation

$311M

Q1 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$437,000-85.9% YoY

Gross Profit

$383,00087.6% margin

Operating Income

-$10M-2327.2% margin

Net Income

-$10M-2245.5% margin

EPS (Diluted)

$-1.55

QoQ Revenue Growth

-70.6%

Cash Flow

Operating Cash Flow

-$5M

Free Cash Flow

-$5M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$134M

Total Liabilities

$19M

Stockholders' Equity

$115M

Cash & Equivalents

$44M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$437,000	$3M	-85.9%
Gross Profit	$383,000	$3M	-87.4%
Operating Income	-$10M	-$2M	-392.5%
Net Income	-$10M	-$2M	-330.4%